CO7131364A2 - Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women - Google Patents

Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women

Info

Publication number
CO7131364A2
CO7131364A2 CO14134455A CO14134455A CO7131364A2 CO 7131364 A2 CO7131364 A2 CO 7131364A2 CO 14134455 A CO14134455 A CO 14134455A CO 14134455 A CO14134455 A CO 14134455A CO 7131364 A2 CO7131364 A2 CO 7131364A2
Authority
CO
Colombia
Prior art keywords
meloxicam
active substance
contraceptive
women
useful
Prior art date
Application number
CO14134455A
Other languages
Spanish (es)
Inventor
Shu-Chen Chen
Original Assignee
Andromaco Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andromaco Lab filed Critical Andromaco Lab
Priority to CO14134455A priority Critical patent/CO7131364A2/en
Publication of CO7131364A2 publication Critical patent/CO7131364A2/en

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

Anillo vaginal de liberación sostenida que comprende meloxicam y un agente modulador de la liberación del principio activo, tal como polivinilpirrolidona K- 30, que libera el principio activo por al menos 90 días, útil como anticonceptivo de uso continuo en mujeres. El anillo vaginal comprende preferentemente 5% a 30% en peso de meloxicam, en relación al peso total de la formulación.Sustained-release vaginal ring comprising meloxicam and an active substance release modulating agent, such as polyvinylpyrrolidone K-30, which releases the active substance for at least 90 days, useful as a contraceptive for continuous use in women. The vaginal ring preferably comprises 5% to 30% by weight of meloxicam, in relation to the total weight of the formulation.

CO14134455A 2014-06-20 2014-06-20 Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women CO7131364A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CO14134455A CO7131364A2 (en) 2014-06-20 2014-06-20 Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CO14134455A CO7131364A2 (en) 2014-06-20 2014-06-20 Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women

Publications (1)

Publication Number Publication Date
CO7131364A2 true CO7131364A2 (en) 2014-12-01

Family

ID=52544101

Family Applications (1)

Application Number Title Priority Date Filing Date
CO14134455A CO7131364A2 (en) 2014-06-20 2014-06-20 Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women

Country Status (1)

Country Link
CO (1) CO7131364A2 (en)

Similar Documents

Publication Publication Date Title
DOP2017000261A (en) CYCLHEXAN DERIVATIVES REPLACED WITH AMIDO
NI201700011A (en) 2- (MORFOLIN-4-IL) -1,7-NAPHTHYRIDINES.
CO2017001493A2 (en) Kits comprising tigit inhibitors and anticancer agents
CL2015001984A1 (en) (divisional sol. 1567-2013) combinations of active ingredients comprising pyridylethylbenzamides and other active ingredients.
CL2019000571A1 (en) Carbamate formulations of (r) -2-amino-3-phenylpropyl.
CR20140365A (en) CARBAMATE COMPOUNDS AND PREPARATION AND USE OF THE SAME
CR20160433A (en) NEW COMPOUNDS
UY37705A (en) NEW BICYCLIC PIRAZOL DERIVATIVES
DOP2017000307A (en) ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARATION OF THE SAME.
AR095691A1 (en) FORMULATION OF AMORFO L-5-METHYLETHYDROPHOLATE (L-5-MTHF-Ca), PROCEDURE, USE
CO2017001842A2 (en) Article and method to maintain menstrual flow inside the vagina
DOP2016000268A (en) AMIDO-AZOLE COMPOUNDS SUBSTITUTED AS TNKS1 AND/OR TNKS2 INHIBITORS
UY36460A (en) PIRAZOLPIRIDINAMINAS
UY35848A (en) TIENOPIRIMIDINS
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
MX2020004063A (en) Systems and methods to produce b cells genetically modified to express selected antibodies.
PE20190210A1 (en) CARRIMYCIN APPLICATIONS IN INFECTION WITH RESISTANT MYCOBACTERIUM TUBERCULOSIS
NI201400066A (en) VAGINAL RING THAT INCLUDES MELOXICAM AND A MODULATING AGENT OF THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN
CO2020002624A2 (en) Formulation for topical use for the control and prevention of parasites in animals
MX2017007856A (en) Oral care composition.
CO7131364A2 (en) Vaginal ring comprising meloxicam and an active substance release modulating agent, useful as a contraceptive for continuous use in women
DOP2014000142A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
ECSP14008154A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS A CONTINUOUS USE CONTRACEPTIVE IN WOMEN
CR20140302A (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS AN ANTI-CONCEPT FOR CONTINUOUS USE IN WOMEN
AR088705A1 (en) VAGINAL RING INCLUDING MELOXICAM AND A MODULATING AGENT FOR THE RELEASE OF THE ACTIVE PRINCIPLE, USEFUL AS A CONTRACEPTIVE FOR CONTINUOUS USE IN WOMEN